Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Return on Equity (2020 - 2025)

NeuroPace has reported Return on Equity over the past 6 years, most recently at 1.12% for Q4 2025.

  • Quarterly results put Return on Equity at 1.12% for Q4 2025, up 196.0% from a year ago — trailing twelve months through Dec 2025 was 1.12% (up 196.0% YoY), and the annual figure for FY2025 was 1.55%, up 36.0%.
  • Return on Equity for Q4 2025 was 1.12% at NeuroPace, up from 1.23% in the prior quarter.
  • Over the last five years, Return on Equity for NPCE hit a ceiling of 0.62% in Q2 2021 and a floor of 3.08% in Q4 2024.
  • Median Return on Equity over the past 5 years was 1.21% (2025), compared with a mean of 1.28%.
  • Biggest five-year swings in Return on Equity: crashed -135bps in 2022 and later skyrocketed 196bps in 2025.
  • NeuroPace's Return on Equity stood at 0.4% in 2021, then crashed by -202bps to 1.2% in 2022, then crashed by -47bps to 1.76% in 2023, then plummeted by -75bps to 3.08% in 2024, then soared by 64bps to 1.12% in 2025.
  • The last three reported values for Return on Equity were 1.12% (Q4 2025), 1.23% (Q3 2025), and 1.17% (Q2 2025) per Business Quant data.